| Net Cash Provided by (Used in) Operating Activities |
$15,913,000 |
USD |
-7.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$20,143,000 |
USD |
-323% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$17,867,000 |
USD |
68% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
23,255,419 |
shares |
|
Q4 2024 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$22,097,000 |
USD |
24% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$30,741,000 |
USD |
-17% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,096,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$82,069,000 |
USD |
179% |
Q4 2025 |
FY 2025 |
| Depreciation |
$3,289,000 |
USD |
26% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$1,108,105,000 |
USD |
20% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$339,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$1,500,000 |
USD |
-25% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,300,000 |
USD |
|
Q3 2024 |
Q3 2024 |